Motor Neuropathy Panel (Testing Alert as of 03/17/18: Refer to Note for details)
0051225
Ordering Recommendation
Aid in diagnosis for motor neuropathy with suspicion for plasma cell dyscrasia.
Mnemonic
MSN PAN
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Quantitative Nephelometry/Quantitative Capillary Electrophoresis/Qualitative Immunofixation Electrophoresis
Performed
Sun-Sat
Reported
1-8 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
- Patient Preparation
- Collect
- Serum separator tube.
- Specimen Preparation
- Separate serum from cells ASAP or within 2 hours of collection. Transfer 4 mL serum to an ARUP Standard Transport Tube. (Min: 2 mL)
- Storage/Transport Temperature
- Refrigerated.
- Unacceptable Conditions
- Plasma, CSF, or other body fluids. Room temperature specimens. Contaminated, heat-inactivated, hemolyzed, severely icteric, or lipemic specimens.
- Remarks
- Stability
- Ambient: Unacceptable; Refrigerated: 2 weeks; Frozen: 1 year
Reference Interval
Test Number | Components | Reference Interval | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
  | Asialo-GM1 Antibodies, IgG/IgM |
| ||||||||
  | GM1 Antibodies, IgG/IgM |
| ||||||||
  | GD1a Antibodies, IgG/IgM |
| ||||||||
  | GD1b Antibodies, IgG/IgM |
| ||||||||
  | GQ1b Antibodies, IgG/IgM |
| ||||||||
  | Total Protein-Electrophoresis | 6.00-8.30 g/dL | ||||||||
  | Albumin | 3.75-5.01 g/dL | ||||||||
  | Alpha 1 Globulin | 0.19-0.46 g/dL | ||||||||
  | Alpha 2 Globulin | 0.48-1.05 g/dL | ||||||||
  | Beta Globulin | 0.48-1.10 g/dL | ||||||||
  | Gamma | 0.62-1.51 g/dL | ||||||||
0050340 | Immunoglobulin A | Effective February 16, 2016
| ||||||||
0050350 | Immunoglobulin G |
| ||||||||
0050355 | Immunoglobulin M | Effective February 16, 2016
| ||||||||
0051285 | Myelin Associated Glycoprotein (MAG) Antibody, IgM | Less than 1000 TU | ||||||||
0051284 | Sulfate-3-Glucuronyl Paragloboside (SGPG) Antibody, IgM | Less than 1.00 IV |
Interpretive Data
Compliance Statement D: For laboratory tests using a manufactured RUO kit. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Note
The Asialo-GM1 Antibodies, IgG/IgM component of this test is unavailable due to a nationwide manufacturer reagent issue. The result of this individual component alone has minimal clinical significance but can support an overall clinical diagnosis in conjunction with other clinical parameters and/or other motor neuropathy markers. The other panel components are not affected by this reagent issue and will be reported within the published turn-around time.
Hotline History
N/A
CPT Code(s)
83516 x7; 84160; 82784 x3; 84165; 86334
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0050020 | Albumin | 2862-1 |
0050035 | Alpha 1 Globulin | 2865-4 |
0050060 | Alpha 2 Globulin | 2868-8 |
0050110 | Beta Globulin | 2871-2 |
0050270 | Gamma | 2874-6 |
0050271 | Immunofixation | 25700-6 |
0050340 | Immunoglobulin A | 2458-8 |
0050350 | Immunoglobulin G | 2465-3 |
0050355 | Immunoglobulin M | 2472-9 |
0050545 | Total Protein-Electrophoresis | 2885-2 |
0051034 | Asialo-GM1 Antibodies, IgG/IgM | 44737-5 |
0051035 | GM1 Antibodies, IgG/IgM | 63244-8 |
0051037 | GD1a Antibodies, IgG/IgM | 48656-3 |
0051038 | GD1b Antibodies, IgG/IgM | 26870-6 |
0051039 | GQ1b Antibodies, IgG/IgM | 31674-5 |
0051284 | SGPG Antibody, IgM | 31666-1 |
0051285 | MAG Antibody, IgM Elisa | 17314-6 |
2005168 | SPEP/IFE Interpretation | 49275-1 |
2012454 | EER Motor Neuropathy Panel | 11526-1 |
Aliases
- Ganglioside Ab, SGPG Ab, MAG Ab, Protein electrophoresis, Alpha, Beta and Gamma globulins